Literature DB >> 15219556

Syphilis and HIV: a dangerous combination.

W A Lynn1, S Lightman.   

Abstract

HIV and syphilis affect similar patient groups and co-infection is common. All patients presenting with syphilis should be offered HIV testing and all HIV-positive patients should be regularly screened for syphilis. Syphilis agent may enhance the transmission of the other, probably through increased incidence of genital ulcers. Detection and treatment of syphilis can, therefore, help to reduce HIV transmission. Syphilis may present with non-typical features in the HIV-positive patient: there is a higher rate of symptomless primary syphilis and proportionately more HIV-positive patients present with secondary disease. Secondary infection may be more aggressive and there is an increased rate of early neurological and ophthalmic involvement. Diagnosis is generally made with serology but the clinician should be aware of the potential for false-negative serology in both primary and, less commonly, in secondary syphilis. All HIV-positive patients should be treated with a penicillin-based regimen that is adequate for the treatment of neurosyphilis. Relapse of infection is more likely in the HIV-positive patient and careful follow-up is required.

Entities:  

Mesh:

Year:  2004        PMID: 15219556     DOI: 10.1016/S1473-3099(04)01061-8

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  113 in total

1.  Necrotic pulmonary nodules in secondary syphilis.

Authors:  Janine B McCready; Roland Skrastins; James F Downey; Jeff E Powis
Journal:  CMAJ       Date:  2010-11-01       Impact factor: 8.262

Review 2.  Syphilis: the renaissance of an old disease with oral implications.

Authors:  Giuseppe Ficarra; Roman Carlos
Journal:  Head Neck Pathol       Date:  2009-07-22

3.  [Enanthema and painful ulceration of the tongue in a young woman].

Authors:  V Kroehl; M Kogut; A H Enk; H A Haenssle
Journal:  Hautarzt       Date:  2016-01       Impact factor: 0.751

4.  A case of secondary syphilis mimicking palmoplantar psoriasis in HIV infected patient.

Authors:  Maraya de Jesus Semblano Bittencourt; Arival Cardoso de Brito; Bianca Angelina Macêdo do Nascimento; Alessandra Haber Carvalho; Manoel Dias do Nascimento
Journal:  An Bras Dermatol       Date:  2015 May-Jun       Impact factor: 1.896

5.  Evaluation of the Treponema pallidum particle agglutination technique (TP.PA) in the diagnosis of neurosyphilis.

Authors:  Rita Castro; Emília S Prieto; Maria João Aguas; Maria José Manata; Júlio Botas; Carlos Araújo; Fernando Borges; Isabel Aldir; Filomena da L Exposto
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

6.  Liver involvement in HIV-infected patients diagnosed with syphilis.

Authors:  N Jung; T Kümmerle; S D Brengelmann; J Gielen; C Lehmann; C Wyen; A Birtel; J Fischer; D Gillor; S Koch; J J Vehreschild; O A Cornely; G Fätkenheuer
Journal:  Infection       Date:  2012-04-25       Impact factor: 3.553

7.  Challenging cases in HIV medicine from Bellevue Hospital: HIV and syphilis--diagnostic and therapeutic approach.

Authors:  Giraldina Trevejo-Nunez; Demetre C Daskalakis
Journal:  MedGenMed       Date:  2007-05-23

8.  The Risk of Sexually Transmitted Infections Following First-Episode Schizophrenia Among Adolescents and Young Adults: A Cohort Study of 220 545 Subjects.

Authors:  Chih-Sung Liang; Ya-Mei Bai; Ju-Wei Hsu; Kai-Lin Huang; Nai-Ying Ko; Hsuan-Te Chu; Ta-Chuan Yeh; Shih-Jen Tsai; Tzeng-Ji Chen; Mu-Hong Chen
Journal:  Schizophr Bull       Date:  2020-07-08       Impact factor: 9.306

9.  Inadvertent use of Bicillin C-R to treat syphilis infection--Los Angeles, California, 1999-2004.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2005-03-11       Impact factor: 17.586

Review 10.  Global challenges in human immunodeficiency virus and syphilis coinfection among men who have sex with men.

Authors:  Chelsea P Roberts; Jeffrey D Klausner
Journal:  Expert Rev Anti Infect Ther       Date:  2016-09-23       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.